08/07/2025 09:36

Ramsay Health Care Ltd (RHC) $39.38

Private hospital operator RHC is on the MM Hitlist after we reviewed the stock in detail earlier this month. Our back-of-the-envelope calculations, plus the markets overall dislike of its investment in Ramsay Sante, could see a 10-15% bullish rerating if/when they exit their holding; they are currently exploring strategies.

Read more

02/07/2025 09:48

Ramsay Health Care Ltd (RHC) $37.5

This morning's review of RHC is well-timed after the stock's 2.3% gain on Tuesday and the rotation out of tech into healthcare in the US overnight: Amgen (AMGN US) and United Health (UNH US) jumped more than 4%, while Merck (MRK US) and Johnson and Johnson (JNJ US) rose more than 3% and about 2%, respectively, lifting the Dow in the process.

Read more

27/02/2025 17:15

Ramsay Healthcare (RHC) $36.18

RHC +6.82% had its best session in years after reporting better than expected revenue and earnings, while they announced a strategic review into its stake in Ramsay Santé 

Read more

19/12/2024 09:29

Ramsay Health Care Ltd (RHC) $35.59

We discussed Atlas Arteria (ALX) earlier in the week, a business that’s struggled over the last few years, not helped by its significant exposure to France – a country still in political turmoil.

Read more

06/12/2024 09:10

Ramsay Health Care (RHC) $40.54

In 2019, the Paul Ramsay Foundation sold a $A1.36 billion stake in RHC at $61.80, a 10.9% stake in Ramsay at the time - the Foundation set up by the late founder remains a major shareholder today.

Read more

26/11/2024 17:07

Ramsay Healthcare (RHC) $39.35

RHC +3.47% showed glimmers of positivity at its AGM today, though nowhere near a turnaround just yet.

Read more

17/07/2024 09:45

Active Growth Portfolio – Amendments

We are making two changes to the Active Growth Portfolio today

Read more

23/05/2024 09:53

Ramsay Health Care Ltd (RHC) $48.86

RHC has been a thorn in our side for more than a year, and the turnaround we’ve been looking for is still not materialising. Fortunately, we purchased RHC after it had fallen ~20% from its KKR bid high, but it's still not a pretty entry of $68.86. We discussed RHC in detail last month and its frustrating exposure to Ramsay Générale de Sante (GDS FP), which has recently been hamstrung by a French government that doesn’t like private healthcare. We liked the company's recent 1H update, but it often takes more than one positive piece of news to be removed from the “naughty corner”.

Read more

24/04/2024 09:29

Ramsay Health Care Ltd (RHC) $52.58

RHC rallied the most in seven weeks on Tuesday as strong buying saw volume increase to 55% above its average of the last 20 days, with 83% of all trades occurring at the offer, i.e. there was a buyer on the prowl. We believe the stocks offering value for investors prepared to look through its French debacle, the position that derailed the bid by KKR at $88 in 2022! Management got a 1 out of 10 regarding its foray into France and how it dealt with KKR’s bid, which should have been grabbed with both hands.

Read more

28/03/2024 09:42

Ramsay Health Care Ltd (RHC) $56.27

RHC has been a huge disappointment to MM—nobody likes to get it wrong! We’re sure KKR is glad they didn't buy the business for $88 per share back in 2022, but we feel the stock is becoming increasingly attractive after its 1H24 update. Recent results demonstrated plenty of improvement in the UK/Euro business, which has been a major area of concern while the Australian business remained solid – its French business was the major stumbling block in the KKR bid.

Read more